These appointments align with the group’s philosophy of having a strong and independent board with exceptional industry experts, ensuring strategic guidance and effective governance
This expanded partnership helps Evonik to streamline its distribution model in Asia Pacific
Illexcor is developing a first-in-class oral drug that directly targets the root cause of SCD
The new lenders – JP Morgan, HSBC, and Barclays provided fresh funding
Overall investment in the US facility is estimated around US$50 million
There are 38.4 million people with diabetes in the United States
The recent EU approval of MBL's plant has opened new avenues to explore such opportunities
The approval marks Venus Remedies’ strategic entry into complex generics, expanding its injectable portfolio beyond traditional formulations
Metropolis Clinical Pathology will acquire and operate all laboratories and collection centers of Scientific Pathology in Agra and neighbouring towns through a slump sale transaction
WuXi XDC's fully integrated ADC discovery service platform will significantly boost the speed and efficiency of LigaChem's ADC development programs
Subscribe To Our Newsletter & Stay Updated
